|
1
|
Yancy CW, Jessup M, Bozkurt B, Butler J,
Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi
JL, et al: 2013ACCF/AHA guideline for the management of heart
failure: A report of the American College of Cardiology
Foundation/American heart association task force on practice
guidelines. J Am Coll Cardiol. 62:e147–e239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McMurray JJ, Adamopoulos S, Anker SD,
Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C,
Gomez-Sanchez MA, et al: ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure 2012: The task force
for the diagnosis and treatment of acute and chronic heart failure
2012 of the European society of cardiology. Developed in
collaboration with the Heart Failure Association (HFA) of the ESC.
Eur Heart J. 33:1787–1847. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hunter JJ and Chien KR: Signaling pathways
for cardiac hypertrophy and failure. N Engl J Med. 341:1276–1283.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Braunwald E: The war against heart
failure: The Lancet lecture. Lancet. 385:812–824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nishida K and Otsu K: Autophagy during
cardiac remodeling. J Mol Cell Cardiol. 95:11–18. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schiattarella GG and Hill JA: Therapeutic
targeting of autophagy in cardiovascular disease. J Mol Cell
Cardiol. 95:86–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Orogo AM and Gustafsson ÅB: Therapeutic
targeting of autophagy: Potential and concerns in treating
cardiovascular disease. Circ Res. 116:489–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Wang J and Yang X: Functions of
autophagy in pathological cardiac hypertrophy. Int J Biol Sci.
11:672–678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lavandero S, Troncoso R, Rothermel BA,
Martinet W, Sadoshima J and Hill JA: Cardiovascular autophagy:
Concepts, controversies, and perspectives. Autophagy. 9:1455–1466.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J and Cai Y: The dual effects of
autophagy in myocardial hypertrophy. Acta Cardiol. 70:493–498.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang LY, Ge X, Wang YL, Ma KL, Liu H,
Zhang XL and Liu BC: Angiotensin receptor blockers reduce left
ventricular hypertrophy in dialysis patients: A meta-analysis. Am J
Med Sci. 345:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Verdecchia P, Gentile G, Angeli F and
Reboldi G: Beyond blood pressure: Evidence for cardiovascular,
cerebrovascular, and renal protective effects of renin-angiotensin
system blockers. Ther Adv Cardiovasc Dis. 6:81–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fagard RH, Celis H, Thijs L and Wouters S:
Regression of left ventricular mass by antihypertensive treatment:
A meta-analysis of randomized comparative studies. Hypertension.
54:1084–1091. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Böhm M, Linz D, Ukena C, Esler M and
Mahfoud F: Renal denervation for the treatment of cardiovascular
high risk-hypertension or beyond? Circ Res. 115:400–409. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bohm M, Ewen S, Kindermann I, Linz D,
Ukena C and Mahfoud F: Renal denervation and heart failure. Eur J
Heart Fail. 16:608–613. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bohm M, Ewen S, Linz D, Reil JC, Schirmer
S, Ukena C and Mahfoud F: Renal denervation: A novel
non-pharmacological approach in heart failure. J Cardiovasc Transl
Res. 7:330–337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brandt MC, Mahfoud F, Reda S, Schirmer SH,
Erdmann E, Böhm M and Hoppe UC: Renal sympathetic denervation
reduces left ventricular hypertrophy and improves cardiac function
in patients with resistant hypertension. J Am Coll Cardiol.
59:901–909. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schirmer SH, Sayed MM, Reil JC, Ukena C,
Linz D, Kindermann M, Laufs U, Mahfoud F and Böhm M: Improvements
in left ventricular hypertrophy and diastolic function following
renal denervation: Effects beyond blood pressure and heart rate
reduction. J Am Coll Cardiol. 63:1916–1923. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mahfoud F, Urban D, Teller D, Linz D,
Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider
G, et al: Effect of renal denervation on left ventricular mass and
function in patients with resistant hypertension: Data from a
multi-centre cardiovascular magnetic resonance imaging trial. Eur
Heart J. 35:2224b–2231b. 2014. View Article : Google Scholar
|
|
20
|
Donazzan L, Mahfoud F, Ewen S, Ukena C,
Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M and
Böhm M: Effects of catheter-based renal denervation on cardiac
sympathetic activity and innervation in patients with resistant
hypertension. Clin Res Cardiol. 105:364–371. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li ZZ, Jiang H, Chen D, Liu Q, Geng J, Guo
JQ, Sun RH, Zhu GQ and Shan QJ: Renal sympathetic denervation
improves cardiac dysfunction in rats with chronic pressure
overload. Physiol Res. 64:653–662. 2015.PubMed/NCBI
|
|
22
|
Jiang W, Tan L, Guo Y, Li X, Tang X and
Yang K: Effect of renal denervation procedure on left ventricular
hypertrophy of hypertensive rats and its mechanisms. Acta Cir Bras.
27:815–820. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cabral AM, Silva IF, Gardioli CR, Mauad H
and Vasquez EC: Diverse effects of renal denervation on ventricular
hypertrophy and blood pressure in DOCA-salt hypertensive rats. Braz
J Med Biol Res. 31:587–590. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Q, Zhang Q, Wang K, Wang S, Lu D, Li
Z, Geng J, Fang P, Wang Y and Shan Q: Renal denervation findings on
cardiac and renal fibrosis in rats with isoproterenol induced
cardiomyopathy. Sci Rep. 5:185822015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xin W, Li X, Lu X, Niu K and Cai J:
Involvement of endoplasmic reticulum stress-associated apoptosis in
a heart failure model induced by chronic myocardial ischemia. Int J
Mol Med. 27:503–509. 2011.PubMed/NCBI
|
|
26
|
Su M, Wang J, Wang C, Wang X, Dong W, Qiu
W, Wang Y, Zhao X, Zou Y, Song L, et al: MicroRNA-221 inhibits
autophagy and promotes heart failure by modulating the
p27/CDK2/mTOR axis. Cell Death Differ. 22:986–999. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Arozena A Acevedo, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu J, Liu F, Liu D, Du H, Hao J, Yang X
and Cui W: Amlodipine and atorvastatin improved hypertensive
cardiac hypertrophy through regulation of receptor activator of
nuclear factor kappa B ligand/receptor activator of nuclear factor
kappa B/osteoprotegerin system in spontaneous hypertension rats.
Exp Biol Med (Maywood). 241:1237–1249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan W, Tang C, Zhu W, Zhu J, Lin Q, Fu Y,
Deng C, Xue Y, Yang M, Wu S and Shan Z: CDK6 mediates the effect of
attenuation of miR-1 on provoking cardiomyocyte hypertrophy. Mol
Cell Biochem. 412:289–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakai A, Yamaguchi O, Takeda T, Higuchi Y,
Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, et
al: The role of autophagy in cardiomyocytes in the basal state and
in response to hemodynamic stress. Nat Med. 13:619–624. 2017.
View Article : Google Scholar
|
|
31
|
Tan LH, Li XG, Guo YZ, Tang XH, Yang K and
Jiang WH: Effect of renal sympathetic denervation on left
ventricular hypertrophy and inflammatory factors in spontaneously
hypertensive rats. Zhejiang Da Xue Xue Bao Yi Xue Ban. 42:550–555.
2013.(In Chinese). PubMed/NCBI
|
|
32
|
Thaung HP, Yao Y, Bussey CT, Hughes G,
Jones PP, Bahn A, Sammut IA and Lamberts RR: Chronic bilateral
renal denervation reduces cardiac hypertrophic remodelling but not
β-adrenergic responsiveness in hypertensive type 1 diabetic rats.
Exp Physiol. 100:628–639. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sridhar S, Botbol Y, Macian F and Cuervo
AM: Autophagy and disease: Always two sides to a problem. J Pathol.
226:255–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dhesi P, Tehrani F, Fuess J and Schwarz
ER: How does the heart (not) die? The role of autophagy in
cardiomyocyte homeostasis and cell death. Heart Fail Rev. 15:15–21.
2010. View Article : Google Scholar : PubMed/NCBI
|
